论文部分内容阅读
目的评价黄芪注射液与左旋卡尼汀联合治疗急性病毒性心肌炎的临床疗效评价结果。方法解放军150医院自2009年6月至2011年6月对收住院的病毒性心肌炎患者90例,应用黄芪注射液与左旋卡尼汀联合治疗,治疗组在对照组常规治疗的基础上加用黄芪注射液50ml/d,左旋卡尼汀3g,加入5%的葡萄糖中静脉滴注。结果 90例患者中经过1次/d静脉注射,14d为一疗程,对照组有效率为73%;治疗组有效率为91%,P<0.05为差别有统计学意义。结论上述药物联合治疗有促进损伤心肌的恢复和改善心功能的作用,无明显的不良反应,应为治疗急性病毒性心肌炎的一种有效方法。
Objective To evaluate the clinical efficacy of astragalus injection combined with levocarnitine in the treatment of acute viral myocarditis. Methods The PLA 150 hospital from June 2009 to June 2011 admitted to hospital patients with viral myocarditis in 90 cases, the application of Astragalus injection combined with L-carnitine treatment group in the control group on the basis of conventional treatment with astragalus Injection 50ml / d, L-carnitine 3g, add 5% glucose intravenous infusion. Results Ninety patients were given intravenous injection once a day for 14 days. The effective rate of the control group was 73%. The effective rate of the treatment group was 91%. P <0.05 was considered as statistically significant. Conclusion The combination therapy of the above drugs can promote the recovery of injured myocardium and improve cardiac function without obvious adverse reactions and should be an effective method for the treatment of acute viral myocarditis.